Literature DB >> 24807727

Cytosolic PrP can participate in prion-mediated toxicity.

Alana M Thackray1, Chang Zhang1, Tina Arndt1, Raymond Bujdoso2.   

Abstract

Prion diseases are characterized by a conformational change in the normal host protein PrPC. While the majority of mature PrPC is tethered to the plasma membrane by a glycosylphosphatidylinositol anchor, topological variants of this protein can arise during its biosynthesis. Here we have generated Drosophila transgenic for cytosolic ovine PrP in order to investigate its toxic potential in flies in the absence or presence of exogenous ovine prions. While cytosolic ovine PrP expressed in Drosophila was predominantly detergent insoluble and showed resistance to low concentrations of proteinase K, it was not overtly detrimental to the flies. However, Drosophila transgenic for cytosolic PrP expression exposed to classical or atypical scrapie prion inocula showed a faster decrease in locomotor activity than similar flies exposed to scrapie-free material. The susceptibility to classical scrapie inocula could be assessed in Drosophila transgenic for panneuronal expression of cytosolic PrP, whereas susceptibility to atypical scrapie required ubiquitous PrP expression. Significantly, the toxic phenotype induced by ovine scrapie in cytosolic PrP transgenic Drosophila was transmissible to recipient PrP transgenic flies. These data show that while cytosolic PrP expression does not adversely affect Drosophila, this topological PrP variant can participate in the generation of transmissible scrapie-induced toxicity. These observations also show that PrP transgenic Drosophila are susceptible to classical and atypical scrapie prion strains and highlight the utility of this invertebrate host as a model of mammalian prion disease. Importance: During prion diseases, the host protein PrPC converts into an abnormal conformer, PrPSc, a process coupled to the generation of transmissible prions and neurotoxicity. While PrPC is principally a glycosylphosphatidylinositol-anchored membrane protein, the role of topological variants, such as cytosolic PrP, in prion-mediated toxicity and prion formation is undefined. Here we generated Drosophila transgenic for cytosolic PrP expression in order to investigate its toxic potential in the absence or presence of exogenous prions. Cytosolic ovine PrP expressed in Drosophila was not overtly detrimental to the flies. However, cytosolic PrP transgenic Drosophila exposed to ovine scrapie showed a toxic phenotype absent from similar flies exposed to scrapie-free material. Significantly, the scrapie-induced toxic phenotype in cytosolic transgenic Drosophila was transmissible to recipient PrP transgenic flies. These data show that cytosolic PrP can participate in the generation of transmissible prion-induced toxicity and highlight the utility of Drosophila as a model of mammalian prion disease.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807727      PMCID: PMC4097767          DOI: 10.1128/JVI.00732-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.

Authors:  Cécile Féraudet; Nathalie Morel; Stéphanie Simon; Hervé Volland; Yveline Frobert; Christophe Créminon; Didier Vilette; Sylvain Lehmann; Jacques Grassi
Journal:  J Biol Chem       Date:  2004-12-23       Impact factor: 5.157

Review 2.  Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology.

Authors:  Sylvie L Benestad; Jean-Noël Arsac; Wilfred Goldmann; Maria Nöremark
Journal:  Vet Res       Date:  2008-01-11       Impact factor: 3.683

3.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene.

Authors:  K Basler; B Oesch; M Scott; D Westaway; M Wälchli; D F Groth; M P McKinley; S B Prusiner; C Weissmann
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

4.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

Review 5.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

6.  Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.

Authors:  Xavier Roucou; Qi Guo; Yan Zhang; Cynthia G Goodyer; Andrea C LeBlanc
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

7.  Neurotoxicity of prion peptides on cultured cerebellar neurons.

Authors:  Giuseppe D Ciccotosto; Roberto Cappai; Anthony R White
Journal:  Methods Mol Biol       Date:  2008

8.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

9.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Experimental oral transmission of atypical scrapie to sheep.

Authors:  Marion M Simmons; S Jo Moore; Timm Konold; Lisa Thurston; Linda A Terry; Leigh Thorne; Richard Lockey; Chris Vickery; Stephen A C Hawkins; Melanie J Chaplin; John Spiropoulos
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

View more
  7 in total

Review 1.  Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.

Authors:  Pedro Fernandez-Funez; Jonatan Sanchez-Garcia; Diego E Rincon-Limas
Journal:  Curr Opin Genet Dev       Date:  2017-04-14       Impact factor: 5.578

Review 2.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

Review 3.  Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response.

Authors:  Raymond Bujdoso; Matthias Landgraf; Walker S Jackson; Alana M Thackray
Journal:  World J Virol       Date:  2015-08-12

4.  The use of PrP transgenic Drosophila to replace and reduce vertebrate hosts in the bioassay of mammalian prion infectivity.

Authors:  Alana M Thackray; Olivier Andréoletti; Raymond Bujdoso
Journal:  F1000Res       Date:  2018-05-15

5.  Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation.

Authors:  Behnam Mohammadi; Luise Linsenmeier; Mohsin Shafiq; Berta Puig; Giovanna Galliciotti; Camilla Giudici; Michael Willem; Thomas Eden; Friedrich Koch-Nolte; Yu-Hsuan Lin; Jörg Tatzelt; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurobiol       Date:  2020-05-04       Impact factor: 5.590

6.  Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease.

Authors:  Alana M Thackray; Brian Lam; Anisa Shahira Binti Ab Razak; Giles Yeo; Raymond Bujdoso
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

7.  The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.

Authors:  Ambadi Thody Sabareesan; Jogender Singh; Samrat Roy; Jayant B Udgaonkar; M K Mathew
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.